Hyperfine (HYPR) Change in Receivables (2021 - 2026)
Hyperfine (HYPR) posted Change in Receivables of -$1.5 million for Q1 2026, down 497.55% on a QoQ basis from $368000.0 in Q4 2025, and down 133.71% year-over-year from $4.3 million in Q1 2025.
Hyperfine (HYPR) Change in Receivables (2021 - 2026) Analysis & Trends
Hyperfine's Change in Receivables history runs 6 years deep, the most recent figure standing at -$1.5 million for Q1 2026.
- Quarterly Change in Receivables fell 133.71% year-over-year to -$1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.5 million (down 11738.46% YoY) and the FY2025 annual result came in at -$702000.0, down 125.37% from the prior year.
- Change in Receivables was -$1.5 million for Q1 2026 at Hyperfine, down from $368000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $2.2 million in Q1 2024 and bottomed at -$1.5 million in Q3 2023.
- A 5-year average of $190470.6 and a median of $43000.0 in 2022 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2023 — Change in Receivables surged 2062.79% — and 2025, when it sank 1192.0%.
- Hyperfine's Change in Receivables stood at -$599000.0 in 2022, then surged by 225.54% to $752000.0 in 2023, then slumped by 212.23% to -$844000.0 in 2024, then surged by 143.6% to $368000.0 in 2025, then slumped by 497.55% to -$1.5 million in 2026.
- Business Quant data shows HYPR's Change in Receivables at -$1.5 million in Q1 2026, $368000.0 in Q4 2025, and -$171000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Hyperfine | 92.81 Mn | 51.53 Mn | 1.98 Mn | -1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.46 Mn |
| Mar 31, 2026 | -1.46 Mn |
| Dec 31, 2025 | 368,000.00 |
| Dec 31, 2025 | 368,000.00 |
| Sep 30, 2025 | -171,000.00 |
| Sep 30, 2025 | -171,000.00 |
| Jun 30, 2025 | -273,000.00 |
| Jun 30, 2025 | -273,000.00 |
| Mar 31, 2025 | -626,000.00 |
| Mar 31, 2025 | -626,000.00 |
| Dec 31, 2024 | -844,000.00 |
| Dec 31, 2024 | -844,000.00 |
| Sep 30, 2024 | 1.43 Mn |
| Sep 30, 2024 | 1.43 Mn |
| Jun 30, 2024 | 25,000.00 |
| Jun 30, 2024 | 25,000.00 |
| Mar 31, 2024 | 2.15 Mn |
| Mar 31, 2024 | 2.15 Mn |
| Dec 31, 2023 | 752,000.00 |
| Dec 31, 2023 | 752,000.00 |